Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that i…
Biotechnology
US, Encinitas [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Ventyx Biosciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDVentyx Biosciences, Inc. can't present revenue by segment